Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
CALL
Blackrock
BLK
$176B
| $9.82M | ﹤0.01% |
12,100
+7,100
| +142% | +$4.96M |
|
1527
Hess Midstream
HESM
$5.11B
| $9.79M | ﹤0.01% |
309,670
+273,281
| +751% | +$8.36M |
|
1528
Agnico Eagle Mines
AEM
$90.5B
| $9.79M | ﹤0.01% |
178,571
+132,167
| +285% | +$6.61M |
|
|
JWN
1529
DELISTED
Nordstrom
JWN
| $9.79M | ﹤0.01% |
530,474
+198,272
| +60% | +$3.04M |
|
1530
Neogen
NEOG
$2.5B
| $9.77M | ﹤0.01% |
485,795
+350,994
| +260% | +$5.94M |
|
1531
Boise Cascade
BCC
$3.02B
| $9.76M | ﹤0.01% |
75,428
+37,437
| +99% | +$4.02M |
|
|
MPT
1532
Medical Properties Trust
MPT
$2.81B
| $9.75M | ﹤0.01% |
1,986,488
+735,204
| +59% | +$3.6M |
|
1533
CALL
Enovix
ENVX
$1.03B
| $9.75M | ﹤0.01% |
889,829
-2,032,685
| -70% | -$20M |
|
1534
PUT
BlackLine
BL
$1.72B
| $9.74M | ﹤0.01% |
156,000
+52,000
| +50% | +$2.94M |
|
1535
KBR
KBR
$4.8B
| $9.72M | ﹤0.01% |
175,436
+103,852
| +145% | +$5.73M |
|
1536
Kymera Therapeutics
KYMR
$8.94B
| $9.72M | ﹤0.01% |
381,781
-7,695
| -2% | -$138K |
|
1537
PUT
iShares Silver Trust
SLV
$30.7B
| $9.71M | ﹤0.01% |
446,000
+346,000
| +346% | +$7.37M |
|
1538
Biohaven
BHVN
$2.21B
| $9.71M | ﹤0.01% |
226,903
+50,990
| +29% | +$1.59M |
|
|
AXON
1539
CALL
Axon Enterprise
AXON
$46.4B
| $9.66M | ﹤0.01% |
37,400
-14,800
| -28% | -$3.34M |
|
1540
Hyatt Hotels
H
$16.7B
| $9.65M | ﹤0.01% |
73,998
+33,090
| +81% | +$3.75M |
|
1541
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $9.65M | ﹤0.01% |
155,865
-3,083
| -2% | -$176K |
|
1542
Huntsman Corp
HUN
$1.77B
| $9.64M | ﹤0.01% |
383,781
+139,839
| +57% | +$3.4M |
|
1543
Advanced Drainage Systems
WMS
$10.9B
| $9.61M | ﹤0.01% |
68,353
+11,645
| +21% | +$1.4M |
|
1544
CALL
TripAdvisor
TRIP
$1.26B
| $9.58M | ﹤0.01% |
+444,900
| New | +$7.8M |
|
1545
CALL
Starbucks
SBUX
$120B
| $9.56M | ﹤0.01% |
99,600
-142,800
| -59% | -$13.9M |
|
1546
PUT
CRISPR Therapeutics
CRSP
$5.17B
| $9.52M | ﹤0.01% |
+152,000
| New | +$8.4M |
|
1547
Mach Natural Resources
MNR
$2.16B
| $9.51M | ﹤0.01% |
+576,515
| New | +$9.99M |
|
1548
Sabesp
SBS
$18.7B
| $9.47M | ﹤0.01% |
3,206,816
| – | – |
|
1549
CALL
Sigma Lithium
SGML
$1.28B
| $9.46M | ﹤0.01% |
+300,000
| New | +$8.37M |
|
1550
PUT
Thermo Fisher Scientific
TMO
$220B
| $9.45M | ﹤0.01% |
17,800
+2,400
| +16% | +$1.16M |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.